DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Found vs Hims & Hers: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Found prints a comparable month-to-month price, $339 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only Found prints a comparable month-to-month price, $269 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Found and Hims & Hers, measure by measure

Found and Hims & Hers side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureFoundHims & Hers
Tirzepatide, month to month$339 (per 28-day cycle)—
Tirzepatide, lowest printed$199 (12-month term, per 28-day cycle)—
Semaglutide, month to month$269 (per 28-day cycle)—
Semaglutide, lowest printed$149 (12-month term, per 28-day cycle)—
Dose pricingpriced by dose or not statednot confirmed
Membership or program feenonenot confirmed
Computed score21 of 40 (position 12 of 27)not scored (brand route)
FDA warning lettersnone listed716567 (2025-09-09); 716825 (2025-09-09)
November 20 readfirst-party read, changednot readable Nov 20

Strengths and limitations: which fits whom

Found bills every 28 days, which adds a 13th charge to the year. Hims & Hers suits someone who wants brand medication, FDA-approved, and accepts a higher monthly cost or has coverage. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Foundtirzepatide—$339
Foundsemaglutide—$269

Regulatory record

FDA’s warning-letter index lists warning letter 716567 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) and warning letter 716825 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) to Hims & Hers; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Found’s current prices ↗
Check Hims & Hers’s current prices ↗

Frequently asked

Which is cheaper, Found or Hims & Hers?

On compounded tirzepatide, only Found prints a comparable month-to-month price, $339 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible. On compounded semaglutide, only Found prints a comparable month-to-month price, $269 per 28-day cycle; Hims & Hers’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.

Do Found and Hims & Hers charge a membership fee?

Found: no membership fee; Hims & Hers: not confirmed on November 20, 2026. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Found and Hims & Hers medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Found recordFound alternativesHims & Hers recordAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.